Equivac HeV vaccine achieves full registration

Hendra Vaccine

Equivac HeV vaccine for Hendra

Zoetis announced today that the Hendra virus vaccine, Equivac® HeV, has received registration from the Australian Pesticides and Veterinary Medicines Authority (APVMA).

The announcement comes after three years of vaccine use within the Australian horse population.
The Equivac HeV passed every APVMA assessment criteria – considered some of the most detailed assessment processes in the world – for registration.

The equine industry should take comfort in knowing that this vaccine has met all the necessary requirements for registration.

The Equivac HeV  vaccine from Zoetis was first made available in response to the growing number of outbreaks and subsequent horse deaths in Queensland and New South Wales in November 2012.
Full registration comes less than two weeks after reports of a second Hendra virus outbreak in as little as four weeks, where a horse was euthanased on a property in far north Queensland.

Lance Williams, General Manager for Zoetis Australia and New Zealand, said today “To date, the Hendra virus has resulted in more than 90 horse deaths and four human deaths. Since November 2012, 14 unvaccinated horses have died from Hendra virus. These deaths could have been prevented with vaccination.”